Global Oral Solid Dosage Excipients Market estimated to be US$ 5.9 billion by 2030 with a CAGR of 7.

Global Oral Solid Dosage Excipients Market accounted for US$ 2.8 billion in 2020 and is estimated to be US$ 5.9 billion by 2030 and is anticipated to register a CAGR of 7.9%. In earlier days, excipients were considered inactive ingredients. Over time, pharmaceutical scientists discovered that excipients are not inactive and frequently have substantial impact on the manufacturer and quality, safety, and efficacy of the drug substance(s) in a dosage form. Tablets and capsules are preferred drug because they can be precisely dosed and packaged on a large scale, and can contribute to good patient compliance.

The report " Global Oral Solid Dosage Excipients Market, By Product Type (Glycerin, Propylene Glycol, Sorbitol, Mannitol and Others), By Form (Crystal, Powder and Others), By Application (Industrial and Non-Industrial) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Trends, Analysis, and Forecast till 2030”

Key Highlights:

Demand for custom drug delivery solutions is increasing and bringing forth an exciting period of valuable, innovative development opportunities.
On 7th Dec, 2020, Evonik acquired Birmingham-Based LACTEL Absorbable Polymers from DURECT Corporation.

To know more

Contact Us:


Prophecy Market Insights

+1 860 531 2701


Leave a Reply

Your email address will not be published. Required fields are marked *